Related by context. All words. (Click for frequent words.) 83 ribavirin RBV 82 Peg IFN 80 Peginterferon 80 pegylated interferon alfa 2a 79 Peginterferon Alfa 2a 78 5 FU leucovorin 78 PEGINTRON TM 78 ritonavir boosted 78 FUSILEV enhances 78 alpha 2a 77 ACTEMRA TM 77 PEGASYS ® 77 dasatinib Sprycel ® 77 Pegasys ® 77 refractory chronic lymphocytic 77 pegylated interferon alpha 76 q8h 76 q#h 76 Peginterferon alfa 2b 76 Copegus ribavirin 76 plus dexamethasone 76 pegylated interferon alpha 2a 76 TO AVOID PREGNANCY WHILE 76 interferon alfa 2a 76 sorafenib tablets 76 COPEGUS R 76 cetuximab Erbitux R 76 ribavirin therapy 76 docetaxel Taxotere ® 76 Pegasys peginterferon alfa 2a 76 Complicated Skin 75 PREZISTA r 75 pegylated interferon peg IFN 75 receiving INTRON 75 peginterferon alfa 2a Pegasys 75 alfa 2b 75 SPRYCEL ® 75 8mg/kg 75 CIMZIA TM 75 Hormone Refractory Prostate Cancer 75 Xeloda ® 75 Paraplatin ® 75 ® lenalidomide 75 Copegus ® 75 cisplatin gemcitabine 75 telaprevir dosed 75 abacavir lamivudine 75 Oral Fingolimod 75 PEGylated anti 75 FEMALES SHOULD BE ADVISED 75 erlotinib Tarceva ® 75 Mg Uk 75 Phase IIb Trial 75 Meets Primary Endpoint 75 FDA APPROVES 75 relapsed MM 75 interferon alfa 2b 75 vapreotide acetate 75 plus COPEGUS 75 ribavirin USP 75 Mg Usa 75 5 fluorouracil leucovorin 75 evaluating tivozanib 75 boosted protease inhibitor 74 plus prednisone prednisolone 74 virus HCV protease inhibitor 74 trastuzumab Herceptin R 74 PEG interferon 74 Pharmacokinetics PK 74 Pegylated Interferon 74 irinotecan doxorubicin oxaliplatin paclitaxel 74 PegIFN 74 peginterferon alpha 2a 74 cyclophosphamide doxorubicin vincristine 74 EPIVIR 74 Pegylated interferon 74 FOLFOX6 74 sorafenib Nexavar 74 ritonavir boosted atazanavir 74 Albuferon TM 74 administered subcutaneously 74 Chronic Hepatitis C 74 Treatment Naive Patients 74 lopinavir r 74 Amgen Neulasta R 74 Camptosar ® 74 Irinotecan 74 FOLFOX6 chemotherapy regimen 74 lenalidomide Revlimid R 74 AZT zidovudine Retrovir 74 mitoxantrone plus 73 adalimumab Humira 73 plus prednisone 73 PEG IFN 73 bortezomib Velcade R 73 potent CYP#A# inhibitors 73 AVASTIN 73 adefovir dipivoxil 73 Platinol ® 73 Tezampanel 73 estramustine 73 Peginterferon alfa 2a 73 PEGylated Fab fragment 73 BARACLUDE ® 73 telaprevir VX 73 peginterferon alfa 73 Interferon alfa 2b 73 R lenalidomide 73 topical gel formulation 73 DOXIL 73 brand ciclesonide HFA 73 Tipranavir 73 Pegasys R 73 R Saizen R 73 VELCADE melphalan 73 biologic DMARD 73 peg interferon 73 sunitinib Sutent ® 73 Naive Patients 73 methylergonovine 73 Zorbtive TM 73 3TC lamivudine Epivir 73 Bosutinib 73 PegIFN RBV 73 mg QD 73 oral rivaroxaban 73 abacavir sulfate lamivudine 73 Aptivus ® 73 non nucleoside inhibitor 73 COPEGUS 73 tenofovir emtricitabine 73 thalidomide Thalomid 73 Pemetrexed 73 5 Fluorouracil 73 Coadministration 73 bevacizumab Avastin R 73 Randomized Phase 73 oral prodrug 73 Darunavir 73 octreotide acetate 73 mapatumumab 73 docetaxel Taxotere R 73 dacarbazine 73 Nebulized 73 docetaxel chemotherapy 73 PRN FDA Approves 73 protease inhibitor PI 72 carboplatin paclitaxel 72 LEXIVA r 72 lamivudine 3TC 72 Moxifloxacin 72 Phase 2b Clinical Trial 72 infliximab monotherapy 72 saline placebo 72 STELARA TM 72 Adefovir 72 valsartan amlodipine 72 liposome injection 72 Aflibercept 72 Vidaza azacitidine 72 pegylated interferon alfa 72 peg IFN 72 Fludara 72 metformin HCl 72 alpha 2b 72 INFERGEN 72 Severe Sepsis 72 cyclophosphamide chemotherapy 72 Relapsed Refractory 72 interferon ribavirin 72 humanized interleukin 6 72 Folfox 72 HGS ETR1 mapatumumab 72 nucleotide analogue 72 Fludara ® 72 methylnaltrexone bromide 72 gemcitabine Gemzar 72 Antitumor Activity 72 myelodysplastic myeloproliferative diseases 72 Vidaza ® 72 Plus Ribavirin 72 capecitabine Xeloda 72 adriamycin 72 REYATAZ R 72 Flu Cy 72 low dose cytarabine 72 Medoxomil 72 IN PATIENTS WITH 72 recurrent glioblastoma multiforme 72 pegylated liposomal doxorubicin 72 Patients Receiving 72 MEK Inhibitor 72 equi analgesic doses 72 TNF Tumor Necrosis Factor 72 lopinavir r arm 72 Single Dose 72 oropharyngeal candidiasis OPC 72 doxorubicin cyclophosphamide 72 Sandostatin R 72 Adjuvant Treatment 72 leukemia AML 72 alpha interferons 72 mg TID 72 interferon beta 1a infertility 72 Investigational Treatment 72 zonisamide SR 72 plus ribavirin 72 peginterferon alfa 2a 72 nevirapine Viramune 72 Doxil ® 72 treatment naive genotype 72 Abrupt discontinuation 72 #mg BID [001] 72 COMBIVIR 72 DOXIL R 72 FOLFIRI 72 Nilotinib 72 Omacetaxine 72 Dementia Related Psychosis 72 atazanavir sulfate 72 galiximab 72 MAGE A3 ASCI 72 Patients Treated With 72 Relapsing Multiple Sclerosis 72 gemcitabine cisplatin 72 Bezielle 72 administered concomitantly 71 oral levofloxacin 71 Neoadjuvant 71 efavirenz EFV 71 Atripla combines 71 tenofovir Viread 71 daunorubicin 71 FOLFOX4 alone 71 treatment naïve genotype 71 weekly subcutaneous injections 71 Nitazoxanide 71 sapropterin dihydrochloride 71 TELINTRA 71 ceftazidime 71 cidofovir 71 LymphoStat B belimumab 71 clodronate 71 forodesine 71 Aztreonam lysine 71 irinotecan containing 71 Loceryl ® 71 Melphalan 71 mycophenolate mofetil 71 Certolizumab 71 paclitaxel Taxol ® 71 interferon gamma 1b 71 cytarabine daunorubicin 71 Heterozygous Familial Hypercholesterolemia 71 Pafuramidine 71 mcg BID 71 tolterodine ER 71 Interferon beta 1a 71 investigational protease inhibitor 71 #mg QD [002] 71 Newly Diagnosed Multiple Myeloma 71 AAG geldanamycin analog 71 zolmitriptan 71 cell lymphoma CTCL 71 Epratuzumab 71 omega interferon 71 budesonide pMDI 71 achieved CCyR 71 FOLFOX4 71 R# #mg BID 71 Adalimumab 71 plus Copegus 71 Ovitrelle R Serostim 71 Phase 2b Trial 71 R rilonacept Injection 71 NS5B polymerase 71 daily Infergen 71 imatinib Gleevec ® 71 Sanofi Pasteur Fluzone 71 pan histone deacetylase 71 CYT# potent vascular disrupting 71 hypertrichosis occurred 71 PREZISTA ritonavir 71 zidovudine lamivudine 71 plus gemcitabine 71 Valopicitabine 71 CHOP chemotherapy 71 standard chemotherapy regimen 71 atazanavir Reyataz 71 TAXOTERE R 71 paclitaxel Taxol 71 anthracycline taxane 71 Ovidrel 71 dacarbazine DTIC 71 #mg/m# [001] 71 paclitaxel Taxol R 71 Mitoxantrone 71 Hycamtin ® 71 Investigational Oral 71 Pooled Analysis 71 hydroxymethyl coenzyme 71 peginterferon alfa 2b 71 lexidronam injection 71 PKC# 71 3mg/kg 71 Pivotal Phase III 71 Peginterferon Alfa 2b 71 melphalan prednisone 71 REVLIMID ® 71 Infected Patients 71 docetaxel Taxotere 71 oral chemotherapeutic agent 71 acyclovir Lauriad R 71 R sorafenib tablets 71 5-FU/LV 71 colesevelam HCl 71 FASLODEX 71 dexamethasone Decadron 71 By JENNIFER LEARN 71 LymphoStat B TM 71 nucleoside analog 71 ergot derivatives 71 ribavirin Copegus ® 71 peginterferon alfa 2a #KD 71 Engerix B 71 INTEGRILIN R 71 R ribavirin USP 71 acetonide FA 71 #mg/m# [002] 71 beta 1a 71 mg/m2 administered 71 bevacizumab Avastin ® 71 Glufosfamide 71 receiving prophylactic anticoagulation 71 demonstrated antitumor activity 71 amoxicillin clavulanate 71 prednisone CHOP 71 #mg BID [003] 71 novel VDA molecule 71 pegIFN 71 mg m² 71 certolizumab 71 Fludarabine 71 developing Bicifadine serotonin 71 ALN HPN 71 #mg q8h 71 Neulasta ® 71 temsirolimus Torisel 71 chemotherapy FOLFOX 71 Treatment Naïve 71 paclitaxel cisplatin 71 nitazoxanide 71 DOXIL ® 71 BARACLUDE R 71 Pegasys plus Copegus 71 Capecitabine 71 infusional 5-FU/LV 71 #mg #mg #mg [003] 71 orally administered inhibitor 70 clopidogrel Plavix 70 metastatic castration resistant 70 Is Well Tolerated 70 mcg QD 70 Amgen Neulasta ® 70 REYATAZ ® 70 metastatic colorectal carcinoma 70 naïve HCV 70 4mg/kg 70 pioglitazone HCl 70 Phase 2b Study 70 ara C 70 μg dose 70 Elotuzumab 70 COPEGUS ribavirin 70 plus methotrexate 70 See CLINICAL PHARMACOLOGY 70 NDA Submission 70 cyclophosphamide methotrexate 70 Romiplostim 70 Acetate Rectal Suppositories 70 salmeterol fluticasone 70 cetuximab Erbitux ® 70 Ziprasidone 70 Study Evaluating 70 hypereosinophilic syndrome 70 pegylated alpha interferon 70 Brentuximab Vedotin SGN 70 Treatment Experienced 70 APTIVUS r 70 amprenavir 70 chronic eosinophilic leukemia 70 inhalations twice 70 intranasal formulation 70 See CONTRAINDICATIONS 70 inhaled corticosteroid ICS 70 Alpha interferons including 70 Adjunctive Therapy 70 CANCIDAS 70 de novo kidney transplant 70 Pegylated Liposomal Doxorubicin 70 Treated Patients 70 Monotherapy 70 Inhalation Aerosol 70 ULORIC 70 Sustiva efavirenz 70 pegylated interferon alfa 2b 70 Copegus 70 oral ridaforolimus 70 R metformin Concor 70 verteporfin 70 metastatic GIST 70 Mylan Receives Approval 70 LEVAQUIN ® 70 primary hypercholesterolemia 70 platelet inhibitor 70 Prolongs Survival 70 Crofelemer budesonide foam 70 mcg dose 70 administered intranasally 70 Alkeran 70 #mg/day [002] 70 Gemzar ® 70 Copegus R 70 CYP#A# substrate 70 idarubicin 70 Pegloticase 70 DEB# 70 plus OBT 70 vinorelbine tartrate 70 CYP#A# CYP#D# 70 mRCC 70 CTAP# Capsules 70 leukotriene receptor antagonist 70 non splenectomized 70 SinuNase TM 70 fluticasone salmeterol 70 Advanced Melanoma 70 Panzem R NCD 70 liposomal formulation 70 PEG INTRON R 70 lapatinib Tykerb 70 inhalation powder 70 Neulasta R 70 baminercept 70 BCG refractory carcinoma 70 IMiDs ® 70 arsenic trioxide injection 70 lopinavir ritonavir Kaletra 70 Initiate Phase 70 dasatinib Sprycel 70 dalteparin 70 Protease Inhibitor 70 Emtriva Viread 70 Tarceva TM 70 GW# [003] 70 Decitabine 70 IMiDs ® compound 70 mycophenolate mofetil MMF 70 Trial Evaluating 70 doxazosin 70 nicardipine 70 II Clinical Trial 70 patients coinfected 70 Interferon Beta 70 emtricitabine tenofovir 70 Vaccine Adjuvant 70 Platinol ® cisplatin 70 anthracyclines taxanes 70 Myelodysplastic Syndrome MDS 70 Cytarabine 70 refractory gout 70 ZOLINZA 70 tazobactam 70 comparator arm 70 Soriatane 70 ORENCIA ® 70 achieved ACR# 70 plus Copegus R 70 PNP inhibitor 70 generation purine nucleoside 70 placebo dexamethasone 70 infusional 70 Orally administered 70 Intravitreal 70 erlotinib Tarceva R 70 Tasigna nilotinib 70 RLAI 70 Serostim ® 70 divalproex sodium 70 Golimumab 70 TNF alpha selectively neutralizing 70 mg BID 70 chlorambucil 70 interferon alfa 70 sorafenib Nexavar R 70 mg RDEA# 69 FIRMAGON 69 gemcitabine carboplatin 69 tinidazole 69 #mg/#mg 69 Bevacizumab 69 CAELYX 69 severe neutropenia 69 somatostatin analog 69 R abacavir sulfate 69 carbamazepine phenobarbital phenytoin rifampin 69 mcg kg 69 Lenalidomide 69 non peptidic protease 69 peginterferon 69 Previously Untreated 69 chemotherapy cisplatin 69 FOLFOX chemotherapy 69 FOLFOX 69 miconazole Lauriad ® 69 Adjunctive 69 headache nasopharyngitis 69 oral nucleoside analogue 69 unfractionated heparin UFH 69 Temsirolimus 69 Novel Oral 69 hour bronchodilation 69 Improves Outcomes 69 Patients Treated 69 #/#.# mcg 69 induced macular edema 69 YONDELIS 69 REVLIMID R 69 Glatiramer Acetate 69 desvenlafaxine succinate 69 dual endothelin receptor antagonist 69 2 methoxyestradiol 69 sitagliptin metformin 69 Temodar ® 69 Boceprevir 69 Vitrasert R 69 APTIVUS 69 vinca alkaloid 69 voriconazole 69 mg qd 69 ZIAGEN 69 IV bolus 69 receptor tyrosine kinase inhibitor 69 Well Tolerated 69 TYKERB 69 lamivudine zidovudine 69 hormone refractory metastatic prostate 69 HCV RESPOND 2 69 TMC# r 69 PEG Intron 69 doxorubicin HCl liposome injection 69 fluvastatin 69 Seliciclib 69 essential thrombocythemia ET 69 including cyclosporine methotrexate 69 refractory cutaneous T 69 1mg 2mg 69 Acute Ischemic Stroke 69 polymerase inhibitor 69 fondaparinux sodium 69 mg eq 69 REBETOL combination therapy 69 nab paclitaxel 69 Telaprevir VX 69 sorafenib Nexavar ® 69 Xelox 69 Bortezomib 69 insulin glulisine 69 candesartan cilexetil 69 Acute Attacks 69 Mycophenolate Mofetil 69 Virologic 69 Lubiprostone 69 CIMZIA TM certolizumab pegol 69 Drug Candidate 69 LPV r 69 Fulvestrant 69 plus DOXIL 69 alkylating agent 69 neutropenia dehydration dyspnea 69 investigational oral hepatitis C 69 Double Blind Placebo 69 CCX# B 69 Azacitidine 69 R adefovir dipivoxil 69 Pegylated 69 hydrochlorothiazide HCTZ 69 selective modulator 69 Navelbine ® 69 Fluticasone 69 Alocrest 69 pyrazinamide 69 Taxotere ® 69 lenalidomide dexamethasone 69 Xyfid TM 69 Ondansetron Injection USP 69 Natalizumab 69 aflibercept VEGF Trap 69 pentostatin 69 Demonstrates Positive 69 abacavir Ziagen 69 INSPIRE Trial Phase III 69 Sapacitabine 69 Long Term Efficacy 69 Ixempra 69 cutaneous T 69 Ribavirin 69 Ribavirin causes 69 Refractory Hodgkin Lymphoma 69 Vandetanib 69 interferon alfacon 1 69 Dose Escalation 69 CorVue ™ 69 Videx Videx EC 69 ATACAND 69 PEG Interferon alfa 69 R bisoprolol Euthyrox 69 gemcitabine chemotherapy 69 dose dexamethasone 69 Begins Dosing 69 5mg/kg 69 Pivotal Phase 69 Known hypersensitivity 69 stage IIIb IV 69 Taxotere chemotherapy 69 itraconazole Sporanox 69 HMG CoA reductase inhibitors 69 Phase III Trial 69 Panzem R 69 vincristine doxorubicin 69 Demonstrates Efficacy 69 metastatic malignant 69 Dasatinib 69 gemtuzumab ozogamicin 69 ® bortezomib 69 LEXIVA 69 FOLOTYN ® 69 Metastatic Prostate Cancer 69 gemcitabine Gemzar ® 69 Humanized Anti 69 pegylated interferon 69 Randomized Double blind 69 Renal Impairment 69 post herpetic neuralgia PHN 69 LENALIDOMIDE 69 Kit CD# positive 69 Trastuzumab 69 Eculizumab 69 Oral Suspension Oral Suspension 69 Elitek 69 cytomegalovirus immune globulin 69 moderate renal impairment 69 intravesical infusion therapy 69 mcg kg REBETOL 69 #mg ritonavir 69 3TC lamivudine 69 immune globulin intravenous 69 First Patient Dosed 69 Dose Ranging Study 69 Gemcitabine 69 Relapsed Refractory Multiple Myeloma 69 Simulect 69 meropenem 69 relapsed refractory multiple myeloma 69 cell carcinoma RCC 69 Antiviral Activity 69 Seasonal Allergic Rhinitis 69 Epivir 69 Vildagliptin 69 Degarelix 69 lintuzumab SGN 69 relapsing remitting MS RRMS 69 zoledronate 69 paclitaxel poliglumex 69 Pazopanib 69 VFEND 69 aripiprazole Abilify 69 HCV SPRINT 69 lopinavir ritonavir 69 Granted Orphan Drug 69 rapid virologic response 69 subcutaneously administered 69 Quinamed 69 Telik logo TELINTRA 69 nilotinib Tasigna ® 69 Placebo Controlled Study 69 Traficet EN 69 cromolyn sodium 69 Cutaneous T 69 TDF FTC 69 haloperidol Haldol 69 Previously Treated 69 Sprycel dasatinib 69 evaluating picoplatin 69 mild renal insufficiency 69 sunitinib malate 69 investigational monoclonal antibody 69 etanercept Enbrel 69 Safinamide 69 PegIntron 69 investigational oral inhibitor 69 Randomized Double Blind 69 Plaque Psoriasis 69 cardiometabolic diseases Glucophage 69 Pharmacokinetic Study 69 nucleoside naive 69 Clevudine 69 dual orexin receptor 69 oral ribavirin 69 blinded randomized placebo controlled 69 cyclophosphamide FC 69 Metastatic Melanoma 68 oral dual endothelin 68 advanced metastatic renal 68 Metastatic Colorectal Cancer 68 Tetanus Toxoids 68 HBeAg + 68 dependent kinase inhibitor 68 oxycodone CR 68 aspirin heparin 68 Polymerase Inhibitor 68 MGd 68 ADP receptor antagonist 68 Demonstrates Potent 68 dextromethorphan quinidine 68 relapsing multiple sclerosis 68 FOLFIRI alone 68 Soft Tissue Sarcoma 68 nadolol 68 piperacillin tazobactam 68 CIMZIA ™ 68 agonistic human 68 Phase III Clinical Trial 68 INTELENCE 68 Ranolazine 68 FOLPI 68 octreotide LAR 68 indinavir Crixivan 68 efalizumab 68 azacytidine 68 Bendamustine 68 fluorouracil leucovorin 68 fluticasone furoate 68 lenalidomide Revlimid ® 68 develop HBV reactivation 68 INVANZ 68 Interferon beta 1b 68 Phase 2a Trial 68 MYCAMINE 68 EMEND 68 Telbivudine 68 Budesonide 68 Tiotropium 68 Receives Orphan Drug Designation 68 Myelofibrosis 68 novel emulsion formulation 68 EFFEXOR XR 68 immunomodulatory therapy 68 Luteinizing Hormone Releasing Hormone 68 Parathyroid Hormone 68 REVLIMID lenalidomide 68 Taxotere docetaxel 68 Follicular Lymphoma 68 fallopian tube carcinoma 68 atazanavir ritonavir 68 pathophysiological effects 68 Completes Patient Enrollment 68 antibody MAb 68 AEGR 68 TTF Therapy 68 Initiate Clinical Trial 68 rosuvastatin Crestor 68 HBeAg positive patients 68 formerly LymphoStat B 68 tipranavir r 68 APTIVUS R 68 cisplatin chemotherapy 68 subcutaneous formulation 68 Achieves Primary Endpoint 68 phase III isavuconazole 68 dihydrochloride Tablets 68 Cyclophosphamide 68 oxaliplatin Eloxatin 68 raloxifene Evista 68 carcinoma mCRC 68 nelfinavir Viracept 68 EUFLEXXA R 68 ALVESCO ® 68 Triapine R 68 DORIBAX 68 mg/m2 IV 68 receiving VELCADE 68 oral proteasome inhibitor 68 systemic RNAi therapeutic 68 ziprasidone Geodon 68 Bevacizumab Avastin 68 Sodium oxybate 68 Hsp# Inhibitor 68 visilizumab 68 TLK# 68 tipranavir 68 Adjuvant Therapy 68 Granulocyte Colony Stimulating Factor 68 receiving immunosuppressive therapy 68 AGILECT R 68 Levofloxacin 68 systemic anaplastic large 68 HGS ETR2 68 Edurant 68 Gemzar gemcitabine 68 hormone LHRH antagonist 68 BRIM2 68 Autologous Stem Cell Transplantation 68 FOR FURTHER INFORMATION ABOUT 68 #/#mg 68 Combination REOLYSIN R 68 metformin sulfonylurea 68 Fluconazole 68 Inhalation Solution 68 Hepatitis C Genotype 68 Wafer polifeprosan 68 antiretroviral naïve 68 PEGylated interferon beta 1a 68 STELARA ® 68 Double Blind Randomized 68 PROCTOCORT R 68 Phase 2a Clinical Trial 68 Expanded Indication 68 Jevtana 68 included exfoliative dermatitis 68 Cloretazine 68 Budesonide foam crofelemer 68 AVONEX ® 68 Relapsing Remitting Multiple Sclerosis 68 bleeding pallor 68 Investigational eFlow Nebulizer System 68 Bicalutamide 68 CHEAP ONLINE PHARMACY LOW 68 bendamustine 68 orally inhaled 68 bacillus Calmette Guerin 68 maximally tolerated dose 68 Initiates Enrollment 68 Captisol Enabled 68 pegfilgrastim 68 unresectable stage 68 Phase IIb Clinical Trial 68 selective A2A adenosine receptor 68 Zoledronic Acid 68 relapsed myeloma 68 receiving PEGINTRON 68 pomalidomide 68 R pramlintide acetate 68 recurrent genital herpes 68 Levoleucovorin 68 PREZISTA rtv 68 HGS# 68 Pioglitazone 68 R roscovitine CDK cyclin 68 ISTODAX ® 68 orally inhaled migraine 68 zidovudine AZT 68 gefitinib Iressa 68 chemoradiation therapy 68 Eraxis 68 continuous intravenous infusion 68 Noxafil 68 Monopril 68 Topotecan 68 prokinetic agent 68 Telithromycin 68 temsirolimus Torisel ® 68 Advanced Prostate Cancer 68 Amrubicin 68 sitaxsentan 68 Indacaterol 68 REYATAZ r 68 Xeloda capecitabine 68 VIVITROL ® 68 Primary Hypercholesterolemia 68 Phase Ib Clinical Trial 68 Improves Survival 68 Orally Disintegrating Tablets 68 % pramoxine HCl 68 tenofovir disoproxil fumarate Viread 68 5 HT3 antagonist 68 saquinavir ritonavir 68 viral kinetics 68 mg/m2 dose 68 r hGH 68 IFN alfa 68 tenofovir FTC 68 Epothilone D 68 Ozarelix 68 NPH insulin 68 TYGACIL 68 Proleukin 68 INTEGRILIN ® 68 fosamprenavir 68 Pentacel R 68 CCyR 68 insulin detemir 68 amphotericin B 68 Teva Provides Update 68 Zevalin R Ibritumomab 68 adjunctive placebo 68 bone marrow reticulin deposition 68 myocardial infarction ventricular fibrillation 68 Intravesical 68 Demonstrate Significant 68 High Dose quadruples 68 Investigational Compound 68 VEGFR2 inhibitor 68 familial amyloidotic polyneuropathy FAP 68 Neupogen ® 68 EGFR TKI 68 invasive aspergillosis 68 invasive candidiasis 68 receiving XGEVA 68 Flovent HFA 68 pimozide 68 XL# anticancer compounds 68 Helicobacter pylori eradication 68 venlafaxine Effexor 68 adalimumab 68 pregabalin Lyrica 68 diarrhea fatigue asthenia 68 PROCRIT ® 68 trimethoprim sulfamethoxazole 68 catheter occlusion 68 plus 5-FU/LV 68 Betaferon R 68 ZYVOX 68 Myeloma Patients 68 AKT inhibitor 68 NEUPOGEN R 68 SELZENTRY 68 flutamide 68 basiliximab 68 Blinatumomab 68 VIRAMUNE 68 cyclophosphamide vincristine 68 HCV Genotype 68 iobenguane 68 indolent follicular non 68 CIMZIA R 68 BENICAR 68 risperidone Risperdal 68 dihydrochloride 68 Campath alemtuzumab 68 serologically active systemic lupus 68 Voreloxin 68 Atypical Hemolytic Uremic Syndrome 68 Orally Active 68 cilengitide 68 imatinib Gleevec 68 Fast Track Status 68 Novacort TM 68 Laquinimod 68 relapsed multiple myeloma 68 ug dose 68 formoterol fumarate 67 oral antidiabetic medication 67 terfenadine 67 darunavir r 67 Fondaparinux 67 Node Positive 67 Posaconazole 67 hyperphenylalaninemia HPA due 67 rizatriptan 67 imipramine Tofranil 67 MyVax R 67 doripenem 67 Enzyme Replacement Therapy 67 RAPTIVA 67 Ambrisentan 67 LANTUS R 67 benzoic acid hyoscyamine sulfate 67 PEGylated interferon 67 Clolar ® 67 Initiate Phase III 67 Herceptin trastuzumab 67 Etravirine 67 letrozole Femara 67 memantine HCl 67 alvespimycin 67 Progressive Multifocal Leukoencephalopathy 67 diarrhea vomiting rash 67 selective phosphodiesterase 67 ODT metoclopramide HCl PEPCID 67 MKC# MT 67 Vicriviroc 67 aspirin clopidogrel 67 Castration Resistant Prostate Cancer 67 Ecallantide 67 carbamazepine Tegretol 67 Elderly Patients 67 Lenocta TM 67 Positive Opinion